Dhairya A Patel
Examiner (ID: 17429, Phone: (571)272-5809 , Office: P/2453 )
Most Active Art Unit | 2453 |
Art Unit(s) | 2451, 2453, 2151, 2455 |
Total Applications | 783 |
Issued Applications | 470 |
Pending Applications | 76 |
Abandoned Applications | 211 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18888928
[patent_doc_number] => 11867695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Compositions and methods for detecting protease activity in biological systems
[patent_app_type] => utility
[patent_app_number] => 17/246167
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 34
[patent_no_of_words] => 43974
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 401
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/246167 | Compositions and methods for detecting protease activity in biological systems | Apr 29, 2021 | Issued |
Array
(
[id] => 17342157
[patent_doc_number] => 20220008488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES
[patent_app_type] => utility
[patent_app_number] => 17/240433
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240433 | Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses | Apr 25, 2021 | Issued |
Array
(
[id] => 17556075
[patent_doc_number] => 11312751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => MHC class I epitope delivering polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/231526
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 71185
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231526
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231526 | MHC class I epitope delivering polypeptides | Apr 14, 2021 | Issued |
Array
(
[id] => 18478480
[patent_doc_number] => 11692212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Diagnosis and treatment of invasive aspergillosis
[patent_app_type] => utility
[patent_app_number] => 17/228382
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 44
[patent_no_of_words] => 13237
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228382
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228382 | Diagnosis and treatment of invasive aspergillosis | Apr 11, 2021 | Issued |
Array
(
[id] => 17429688
[patent_doc_number] => 20220057397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSING LYME DISEASE AND FOR PREDICTING LYME DISEASE SPIROCHETE ELIMINATION AFTER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/200553
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 490
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/200553 | COMPOSITIONS AND METHODS FOR DIAGNOSING LYME DISEASE AND FOR PREDICTING LYME DISEASE SPIROCHETE ELIMINATION AFTER TREATMENT | Mar 11, 2021 | Pending |
Array
(
[id] => 16946754
[patent_doc_number] => 20210205445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => Vaccine Adjuvant
[patent_app_type] => utility
[patent_app_number] => 17/186366
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/186366 | Vaccine Adjuvant | Feb 25, 2021 | Pending |
Array
(
[id] => 16883819
[patent_doc_number] => 20210170014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN INFLAMMATORY DISEASE OR DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/178412
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178412
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178412 | COMPOSITIONS AND METHODS FOR TREATING AN INFLAMMATORY DISEASE OR DISORDER | Feb 17, 2021 | Abandoned |
Array
(
[id] => 16825671
[patent_doc_number] => 20210140964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => PEPTIDES AND METHODS FOR THE DETECTION OF LYME DISEASE ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/149227
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 341
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149227
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/149227 | Peptides and methods for the detection of Lyme disease antibodies | Jan 13, 2021 | Issued |
Array
(
[id] => 16946739
[patent_doc_number] => 20210205430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => VIRB10 FOR VACCINATION AGAINST GRAM NEGATIVE BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/142792
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17142792
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/142792 | VIRB10 FOR VACCINATION AGAINST GRAM NEGATIVE BACTERIA | Jan 5, 2021 | Pending |
Array
(
[id] => 16778309
[patent_doc_number] => 20210115387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => APPARATUS AND METHOD FOR PROCESSING SAMPLES CONTAINING BIOLOGICAL CELLS
[patent_app_type] => utility
[patent_app_number] => 17/133589
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133589
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133589 | APPARATUS AND METHOD FOR PROCESSING SAMPLES CONTAINING BIOLOGICAL CELLS | Dec 22, 2020 | Pending |
Array
(
[id] => 16750867
[patent_doc_number] => 20210102876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => TESTING FOR PARTICULATES
[patent_app_type] => utility
[patent_app_number] => 17/122594
[patent_app_country] => US
[patent_app_date] => 2020-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -136
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17122594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/122594 | TESTING FOR PARTICULATES | Dec 14, 2020 | Pending |
Array
(
[id] => 17874374
[patent_doc_number] => 11446367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Immunization with polyvalent venom vaccines
[patent_app_type] => utility
[patent_app_number] => 17/115827
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4344
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17115827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/115827 | Immunization with polyvalent venom vaccines | Dec 8, 2020 | Issued |
Array
(
[id] => 16750222
[patent_doc_number] => 20210102231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => METHODS FOR CONTROLLING PROTEASE PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/116353
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116353
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116353 | METHODS FOR CONTROLLING PROTEASE PRODUCTION | Dec 8, 2020 | Pending |
Array
(
[id] => 16688650
[patent_doc_number] => 20210071126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => CELL CULTURE DEVICE AND STIRRING METHOD
[patent_app_type] => utility
[patent_app_number] => 16/953340
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16953340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/953340 | CELL CULTURE DEVICE AND STIRRING METHOD | Nov 19, 2020 | Pending |
Array
(
[id] => 18762916
[patent_doc_number] => 11813295
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-11-14
[patent_title] => Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
[patent_app_type] => utility
[patent_app_number] => 17/093133
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 11
[patent_no_of_words] => 19410
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17093133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/093133 | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity | Nov 8, 2020 | Issued |
Array
(
[id] => 16612206
[patent_doc_number] => 20210030859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => USES OF PARASITE MACROPHAGE MIGRATION INHIBITORY FACTORS
[patent_app_type] => utility
[patent_app_number] => 17/073006
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073006
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073006 | USES OF PARASITE MACROPHAGE MIGRATION INHIBITORY FACTORS | Oct 15, 2020 | Abandoned |
Array
(
[id] => 18116360
[patent_doc_number] => 11547732
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-10
[patent_title] => Human-derived bacteria that induce proliferation or accumulation of regulatory T cells
[patent_app_type] => utility
[patent_app_number] => 17/071425
[patent_app_country] => US
[patent_app_date] => 2020-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 42
[patent_no_of_words] => 33488
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17071425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/071425 | Human-derived bacteria that induce proliferation or accumulation of regulatory T cells | Oct 14, 2020 | Issued |
Array
(
[id] => 16718632
[patent_doc_number] => 20210085779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => PD1 AND PDL1 ANTIBODIES AND VACCINE COMBINATIONS AND USE OF SAME FOR IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/063977
[patent_app_country] => US
[patent_app_date] => 2020-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063977
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063977 | PD1 AND PDL1 ANTIBODIES AND VACCINE COMBINATIONS AND USE OF SAME FOR IMMUNOTHERAPY | Oct 5, 2020 | Pending |
Array
(
[id] => 16582836
[patent_doc_number] => 20210017238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => Antigenic OspA Polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/061155
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/061155 | Antigenic OspA Polypeptides | Sep 30, 2020 | Pending |
Array
(
[id] => 18478497
[patent_doc_number] => 11692229
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Fast diagnosis and personalized treatments for acne
[patent_app_type] => utility
[patent_app_number] => 17/033034
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 41
[patent_no_of_words] => 37968
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17033034
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/033034 | Fast diagnosis and personalized treatments for acne | Sep 24, 2020 | Issued |